Why the study?
Tachycardia-induced cardiomyopathy is rare during pregnancy, and its management can be complex due to the fetal risks of antiarrhythmic medications and cardiac interventions.
Case Report (n=1)
Describes a rare case of recurrent atrial tachycardia-induced cardiomyopathy during pregnancy highlighting the need for multidisciplinary management.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary management of rare tachycardia-induced cardiomyopathy in pregnancy; leaves open optimal antiarrhythmic strategies.
Tachycardia-induced cardiomyopathy is rare during pregnancy and is reversible when the underlying arrhythmia is effectively treated. Management can be complex due to the risks of antiarrhythmic medications and cardiac interventions on the developing fetus. The care requires a well-coordinated multidisciplinary team of cardiologists, electrophysiologists, and maternal-fetal specialists. In this report, we describe a case of recurrent atrial tachycardia-induced cardiomyopathy in pregnancy.
No takes yet. Share an insight, caveat, or question.
A 2020 study conducted a case report in Tachycardia-induced cardiomyopathy in pregnancy (n=1). Medical management and catheter ablation was evaluated on Resolution of tachycardia-induced cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: